FDA OKs Abilify for secondary use against bipolar disorder
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
FDA OKs Abilify for secondary use against bipolar disorder
8 May 08, 22:41
AP 05.08.08, 6:27 PM ET Bristol-Myers Squibb Co. and Japanese partner Otsuka Pharmaceutical Co. said Thursday federal regulators expanded approval for ...
more

 

 
© 2007 nafdacnigeria.org